INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
389.83 |
331.40 |
|
386.41 |
353.08 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
|
- |
- |
Other Revenue |
-0.38 |
-0.88 |
|
-0.65 |
0.00 |
Total Revenue |
389.45 |
330.52 |
290.96 |
385.76 |
353.08 |
Cost of Goods and Services Sold |
278.00 |
241.00 |
209.43 |
271.00 |
251.81 |
Gross
Profit |
111.45 |
89.52 |
81.53 |
114.76 |
101.27 |
Selling, Administration, Marketing |
83.89 |
74.73 |
70.33 |
79.78 |
73.84 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
2.56 |
0.19 |
1.26 |
0.18 |
0.29 |
Other operatinig exp. /-income |
0.02 |
-0.02 |
0.00 |
0.00 |
-0.05 |
Legal Fees |
- |
- |
- |
- |
- |
Total operating costs including COS |
364.46 |
315.90 |
281.02 |
350.95 |
325.90 |
Operating income/-loss
|
24.99 |
14.62 |
9.95 |
34.81 |
27.18 |
Other Deductions / - Income |
Interest expense |
- |
2.07 |
2.52 |
3.62 |
3.28 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
2.07 |
2.52 |
3.62 |
3.28 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-2.20 |
-0.82 |
0.43 |
-1.73 |
-0.80 |
Interest Expense Nonoperating |
2.75 |
- |
- |
- |
- |
Total costs & expenses |
365.01 |
317.15 |
283.97 |
352.84 |
328.38 |
Income /-loss before income taxes |
24.43 |
13.37 |
6.99 |
32.92 |
24.70 |
Income taxes expenses/-benefit |
6.11 |
3.34 |
-0.29 |
8.00 |
6.29 |
Income after income taxes |
18.32 |
10.03 |
7.28 |
24.92 |
18.41 |
Net income/-loss
of other equity |
0.00 |
- |
0.00 |
- |
- |
Income/-loss
from cont. Ops. |
18.32 |
10.03 |
7.28 |
24.92 |
18.41 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-0.92 |
-1.04 |
-0.80 |
-18.20 |
-9.22 |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
17.41 |
8.99 |
6.49 |
6.72 |
9.19 |
Noncontrolling interests |
0.34 |
0.17 |
0.05 |
0.06 |
0.05 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
17.06 |
8.82 |
6.43 |
6.66 |
9.14 |
EBIT |
24.43 |
15.44 |
9.51 |
36.54 |
27.98 |
EBITD |
31.75 |
22.74 |
17.08 |
43.87 |
35.03 |
EBITDA |
31.87 |
22.86 |
17.20 |
43.99 |
35.15 |